<!DOCTYPE html>
<html lang="ko">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>RegScan - Hot Issue 브리핑</title>
    <script src="https://cdn.tailwindcss.com"></script>
    <style>
        @import url('https://fonts.googleapis.com/css2?family=Noto+Sans+KR:wght@400;500;600;700&family=Inter:wght@400;500;600&display=swap');
        body { font-family: 'Noto Sans KR', sans-serif; background: #f8fafc; }
        .line-clamp-2 { display: -webkit-box; -webkit-line-clamp: 2; -webkit-box-orient: vertical; overflow: hidden; }
    </style>
</head>
<body class="min-h-screen">
    <header class="bg-white border-b border-gray-200">
        <div class="max-w-6xl mx-auto px-6 py-6">
            <div class="flex items-center justify-between">
                <div>
                    <h1 class="text-2xl font-bold text-gray-900">RegScan Hot Issue</h1>
                    <p class="text-sm text-gray-500 mt-1">글로벌 규제 동향 브리핑 리포트</p>
                </div>
                <div class="text-sm text-gray-500">2026년 02월 13일</div>
            </div>
        </div>
    </header>
    <main class="max-w-6xl mx-auto px-6 py-10">
        <div class="mb-8">
            <h2 class="text-lg font-semibold text-gray-800">핫이슈 약물 (5건)</h2>
            <p class="text-sm text-gray-500">글로벌 규제 동향 + 국내 도입 전망 브리핑</p>
        </div>
        <div class="grid grid-cols-1 md:grid-cols-2 lg:grid-cols-3 gap-6">
            <a href="polatuzumab_vedotin.html" class="block bg-white rounded-xl shadow-sm hover:shadow-md transition-shadow border border-gray-100 overflow-hidden">
                <div class="p-6">
                    <div class="flex items-center justify-between mb-3">
                        <span class="px-2 py-1 bg-orange-100 text-orange-700 text-xs font-bold rounded">
                            Score 60
                        </span>
                        <span class="text-xs text-gray-400">expected</span>
                    </div>
                    <h3 class="font-bold text-lg text-gray-900 mb-2">POLATUZUMAB VEDOTIN</h3>
                    <p class="text-sm text-gray-600 line-clamp-2">CD79b를 타겟하는 항체-약물 접합체(ADC)로, 재발·불응성 미만성 거대 B세포 림프종(DLBCL) 치료에 사용...</p>
                    <div class="mt-4 flex items-center text-xs text-gray-500"></div>
                </div>
            </a>
            <a href="zanidatamab-hrii.html" class="block bg-white rounded-xl shadow-sm hover:shadow-md transition-shadow border border-gray-100 overflow-hidden">
                <div class="p-6">
                    <div class="flex items-center justify-between mb-3">
                        <span class="px-2 py-1 bg-orange-100 text-orange-700 text-xs font-bold rounded">
                            Score 60
                        </span>
                        <span class="text-xs text-gray-400">expected</span>
                    </div>
                    <h3 class="font-bold text-lg text-gray-900 mb-2">ZANIDATAMAB-HRII</h3>
                    <p class="text-sm text-gray-600 line-clamp-2">HER2 양성 진행성 담관암 치료에 사용되는 항체로, HER2 단백질을 표적으로 한 항암제...</p>
                    <div class="mt-4 flex items-center text-xs text-gray-500"></div>
                </div>
            </a>
            <a href="zolbetuximab.html" class="block bg-white rounded-xl shadow-sm hover:shadow-md transition-shadow border border-gray-100 overflow-hidden">
                <div class="p-6">
                    <div class="flex items-center justify-between mb-3">
                        <span class="px-2 py-1 bg-yellow-100 text-yellow-700 text-xs font-bold rounded">
                            Score 55
                        </span>
                        <span class="text-xs text-gray-400">expected</span>
                    </div>
                    <h3 class="font-bold text-lg text-gray-900 mb-2">ZOLBETUXIMAB</h3>
                    <p class="text-sm text-gray-600 line-clamp-2">ZOLBETUXIMAB은 클라우딘 18.2를 표적하는 항체의약품으로, HER2 음성 위암 환자의 1차 치료에 활용되며, 화학요법과 병용하여 효과...</p>
                    <div class="mt-4 flex items-center text-xs text-gray-500"></div>
                </div>
            </a>
            <a href="ivosidenib.html" class="block bg-white rounded-xl shadow-sm hover:shadow-md transition-shadow border border-gray-100 overflow-hidden">
                <div class="p-6">
                    <div class="flex items-center justify-between mb-3">
                        <span class="px-2 py-1 bg-yellow-100 text-yellow-700 text-xs font-bold rounded">
                            Score 55
                        </span>
                        <span class="text-xs text-gray-400">expected</span>
                    </div>
                    <h3 class="font-bold text-lg text-gray-900 mb-2">IVOSIDENIB</h3>
                    <p class="text-sm text-gray-600 line-clamp-2">IVOSIDENIB은 IDH1 R132 변이를 가진 급성 골수성 백혈병(AML) 환자 치료에 사용되는 약물로, 세포 대사 경로를 조절하여 암세포...</p>
                    <div class="mt-4 flex items-center text-xs text-gray-500"></div>
                </div>
            </a>
            <a href="talquetamab.html" class="block bg-white rounded-xl shadow-sm hover:shadow-md transition-shadow border border-gray-100 overflow-hidden">
                <div class="p-6">
                    <div class="flex items-center justify-between mb-3">
                        <span class="px-2 py-1 bg-yellow-100 text-yellow-700 text-xs font-bold rounded">
                            Score 55
                        </span>
                        <span class="text-xs text-gray-400">expected</span>
                    </div>
                    <h3 class="font-bold text-lg text-gray-900 mb-2">TALQUETAMAB</h3>
                    <p class="text-sm text-gray-600 line-clamp-2">TALQUETAMAB는 CD3 및 BCMA를 타겟으로 한 이중 작용 기전의 단독 요법으로, 재발 및 불응성 다발골수종 환자에게 사용...</p>
                    <div class="mt-4 flex items-center text-xs text-gray-500"></div>
                </div>
            </a>

        </div>
    </main>
    <footer class="border-t border-gray-200 mt-16 py-8">
        <div class="max-w-6xl mx-auto px-6 text-center text-sm text-gray-400">
            RegScan AI - 글로벌 의약품 규제 인텔리전스
        </div>
    </footer>
</body>
</html>